Federated Hermes Inc. Sells 64,794 Shares of Danaher Corporation $DHR

Federated Hermes Inc. lowered its stake in shares of Danaher Corporation (NYSE:DHR) by 31.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 143,628 shares of the conglomerate’s stock after selling 64,794 shares during the period. Federated Hermes Inc.’s holdings in Danaher were worth $28,372,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Red Tortoise LLC boosted its holdings in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after acquiring an additional 98 shares in the last quarter. Ramirez Asset Management Inc. acquired a new position in shares of Danaher during the second quarter worth approximately $40,000. Twin Peaks Wealth Advisors LLC bought a new position in shares of Danaher in the 2nd quarter worth $51,000. Saudi Central Bank acquired a new stake in Danaher in the 1st quarter valued at $52,000. Finally, Sittner & Nelson LLC increased its stake in Danaher by 36.9% during the 2nd quarter. Sittner & Nelson LLC now owns 371 shares of the conglomerate’s stock valued at $73,000 after purchasing an additional 100 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of recent research reports. Rothschild & Co Redburn reaffirmed a “neutral” rating and issued a $220.00 price objective (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Barclays lifted their price target on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. The Goldman Sachs Group initiated coverage on Danaher in a report on Tuesday. They issued a “buy” rating and a $265.00 target price on the stock. Finally, Morgan Stanley started coverage on Danaher in a research report on Monday, December 1st. They issued an “overweight” rating and a $270.00 price target for the company. Twenty-one equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $246.79.

Insider Activity

In other Danaher news, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the sale, the senior vice president directly owned 2,625 shares of the company’s stock, valued at $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the transaction, the senior vice president owned 14,553 shares of the company’s stock, valued at $3,190,454.19. The trade was a 59.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 30,248 shares of company stock valued at $6,609,663 in the last 90 days. Insiders own 11.20% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $223.51 on Wednesday. The company has a market capitalization of $157.87 billion, a PE ratio of 46.08, a price-to-earnings-growth ratio of 4.36 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23. The company has a 50-day simple moving average of $217.50 and a 200 day simple moving average of $205.01.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.71 EPS. On average, research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s payout ratio is presently 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.